Klaus Okkenhaug

Klaus Okkenhaug is a Fellow at the University of Cambridge, affiliated with the School of Biological Sciences. His research focuses on Immunity, Infection, Cancer, Cell signalling, and PI3K. His work explores how phosphoinositide 3-kinases (PI3Ks) are used by immune cells to coordinate defences against pathogens. His research areas include techniques such as Flow cytometry, Fluorescence-activated cell sorting (FACS), Imaging, RNA sequencing, Proteomics, and Biochemistry. His profile page provides further details on his research themes.

Klaus Okkenhaug is a leading researcher in immunology, focusing on cell signaling mechanisms and their implications in disease. His work explores the role of phosphoinositide 3-kinase (PI3K) in immune function, particularly in cancer immunotherapy and primary immunodeficiencies. Okkenhaug's research investigates how PI3K signaling influences lymphocyte development, differentiation, and activation, as well as its involvement in immune tolerance and tumor microenvironment dynamics. His studies also highlight the importance of PI3K in allergic responses and regulatory T-cell function. Through these investigations, Okkenhaug contributes to understanding the molecular basis of immune disorders and potential therapeutic strategies.